{"id":"W4200276328","doi":"10.1097/ppo.0000000000000557","title":"With Our Powers Combined: Exploring PARP Inhibitors and Immunotherapy.","year":2022,"lang":"en","type":"article","venue":"PubMed","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Poly ADP ribose polymerase; PARP inhibitor; Clinical trial; Medicine; Immunotherapy; Biomarker; Drug; Ovarian cancer; Drug development; Oncology; Cancer research; Cancer; Polymerase; Pharmacology; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009291543,0.000557865,0.0005458957,0.0007624613,0.0004702841,0.002186435,0.0005434862,0.001306952,0.01322619],"category_scores_gemma":[0.001159615,0.0001777679,0.0006543741,0.0007628556,0.0006317406,0.002617773,0.0009661332,0.002592371,0.004877209],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006133322,"about_ca_system_score_gemma":0.001114793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006169995,"about_ca_topic_score_gemma":0.001957063,"domain_scores_codex":[0.9996793,0.00008705713,0.00002553382,0.00005067408,0.0001085935,0.00004891335],"domain_scores_gemma":[0.999604,0.0001257563,0.00007775054,0.0000216767,0.00009882823,0.00007205365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003378769,0.0001440717,0.0005134169,0.004717021,0.0001334952,0.0005212959,0.0002032035,0.0003026791,0.005978848,0.01447713,0.1339231,0.8387479],"study_design_scores_gemma":[0.00009037756,0.000540628,0.00100423,0.002662327,0.0001307737,0.001649199,0.0002313511,0.0001602859,0.002316707,0.009881115,0.981306,0.00002682912],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001888872,0.9467385,0.001281102,0.02142704,0.005029404,0.00005772853,0.0001654393,0.00008674951,0.02332508],"genre_scores_gemma":[0.02307639,0.9150289,0.002756858,0.02111025,0.004856846,0.00007397652,0.0002711707,0.0000385841,0.03278698],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01322619,"threshold_uncertainty_score":0.04424596,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04303746637506662,"score_gpt":0.2461532675923246,"score_spread":0.2031158012172579,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}